Daniel J. Curran

Insider Reports History

Location
Waltham, MA
Signature
/s/ Daniel J. Curran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel J. Curran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CATALYST PHARMACEUTICALS, INC. Director Common Stock, par value $0.001 per share 0 $0 $21.70 Aug 1, 2025 Direct
CATALYST PHARMACEUTICALS, INC. Director Restricted Stock Units 63.6K Nov 20, 2025 Direct
CATALYST PHARMACEUTICALS, INC. Director Options to purchase common stock 58.1K Nov 20, 2025 Direct
ALX ONCOLOGY HOLDINGS INC Director Stock option (right to buy) 40.4K Aug 12, 2025 Direct
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 31K Jun 11, 2025 Direct

Insider Reports Filed by Daniel J. Curran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CPRX CATALYST PHARMACEUTICALS, INC. Nov 20, 2025 2 $0 4 Nov 24, 2025 Director
ALXO ALX ONCOLOGY HOLDINGS INC Aug 12, 2025 1 $0 4 Aug 13, 2025 Director
ALXO ALX ONCOLOGY HOLDINGS INC Aug 12, 2025 0 $0 3 Aug 13, 2025 Director
CPRX CATALYST PHARMACEUTICALS, INC. Aug 1, 2025 0 $0 3 Aug 8, 2025 Director
XLO Xilio Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 12, 2025 Director
XLO Xilio Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Director